Reshaping the HIV treatment and prevention landscape

Improved capital position supports growth investment Vaccines Strong operating cash flow Capital allocation priorities Strengthen pipeline (including bolt-on and in-licensing BD) Specialty Medicines + General Medicines Product launches Strengthened balance sheet Sustainability Progressive dividend policy gsk 21

View entire presentation